European Registry of Type A Aortic Dissection

NCT04831073 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3902

Last updated 2024-12-11

No results posted yet for this study

Summary

Acute Stanford type A aortic dissection (TAAD) is a life-threatening condition. Surgery is usually performed as a salvage procedure and is associated with significant postoperative early mortality and morbidity. Understanding the patient's conditions and treatment strategies which are associated with these adverse events is essential for an appropriate management of acute TAAD.

Conditions

  • Type A Aortic Dissection

Interventions

PROCEDURE

Surgery on the ascending aorta with or without repair of the aortic root and/or aortic arch

Surgical repair of the ascending aorta with or without surgical repair of the aortic root and/or aortic arch

Sponsors & Collaborators

  • University Hospitals, Leicester

    collaborator OTHER
  • University Hospital Southampton NHS Foundation Trust

    collaborator OTHER
  • Azienda Ospedaliera Universitaria Integrata Verona

    collaborator OTHER
  • Centre Hospitalier Universitaire de Besancon

    collaborator OTHER
  • Assistance Publique - Hôpitaux de Paris

    collaborator OTHER
  • Ziekenhuis Oost-Limburg

    collaborator OTHER
  • University Hospital Muenster

    collaborator OTHER
  • University of Hamburg-Eppendorf

    collaborator OTHER
  • Institute for Clinical and Experimental Medicine

    collaborator OTHER_GOV
  • Northern General Hospital, Herries Road, Sheffield

    collaborator UNKNOWN
  • Liverpool Heart and Chest Hospital NHS Foundation Trust

    collaborator OTHER
  • University Hospital, Udine, Italy

    collaborator OTHER
  • Heart Center Leipzig - University Hospital

    collaborator OTHER
  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    collaborator OTHER
  • AZ Sint-Jan AV

    collaborator OTHER
  • University Hospital, Antwerp

    collaborator OTHER
  • Universitaire Ziekenhuizen KU Leuven

    collaborator OTHER
  • University of Turin, Italy

    collaborator OTHER
  • University of Barcelona

    collaborator OTHER
  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Fausto Biancari · Helsinki University Hospital, Helsinki, Finland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-28
Primary Completion
2024-12-06
Completion
2024-12-06

Countries

  • Belgium
  • Czechia
  • Finland
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04831073 on ClinicalTrials.gov